{
    "startDate": "2021-01-01",
    "endDate": "2021-12-31",
    "year": "2021",
    "quarter": "FY",
    "symbol": "DYAI",
    "data": {
        "bs": [
            {
                "label": "Total stockholders\u2019 equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 18390462
            },
            {
                "label": "Total stockholders\u2019 equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 18390462
            },
            {
                "label": "Deferred license revenue, current portion",
                "concept": "dyai:DeferredLicenseRevenueCurrent",
                "unit": "usd",
                "value": 147059
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 2555719
            },
            {
                "label": "Interest receivable",
                "concept": "InterestReceivableCurrent",
                "unit": "usd",
                "value": 94375
            },
            {
                "label": "Treasury stock, shares held at cost - 12,253,502",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 18929915
            },
            {
                "label": "Treasury stock, shares held at cost - 12,253,502",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 18900000.0
            },
            {
                "label": "Total liabilities and stockholders\u2019 equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 21299122
            },
            {
                "label": "Investment in Alphazyme",
                "concept": "dyai:PrepaidResearchAndDevelopmentInProcessCurrent",
                "unit": "usd",
                "value": 284709
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 21299122
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 1547953
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 1547953
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 21008296
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 375830
            },
            {
                "label": "Commitments and contingencies (Note 5)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, $.0001 par value: Authorized shares - 5,000,000; none issued and outstanding",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 6117
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 709560
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 15748480
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 15748480
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 277831
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 277831
            },
            {
                "label": "Deferred research and development obligations",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 151147
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 2908660
            },
            {
                "label": "Deferred license revenue, net of current portion",
                "concept": "dyai:DeferredLicenseRevenueNetOfCurrentPortion",
                "unit": "usd",
                "value": 352941
            },
            {
                "label": "Common stock, $.001 par value:Authorized shares - 100,000,000; issued shares - 40,332,659 and 39,747,659, outstanding shares - 28,079,157 and 27,494,157 as of June 30, 2021, and December 31, 2020, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 40483
            },
            {
                "label": "Short-term investment securities",
                "concept": "HeldToMaturitySecuritiesCurrent",
                "unit": "usd",
                "value": 4511780
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -63746602
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 101026496
            }
        ],
        "cf": [
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 31792
            },
            {
                "label": "Effect of exchange rate changes on cash",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
                "unit": "usd",
                "value": -63262
            },
            {
                "label": "Income tax receivable",
                "concept": "IncreaseDecreaseInIncomeTaxesReceivable",
                "unit": "usd",
                "value": ""
            },
            {
                "label": "Foreign currency exchange loss",
                "concept": "ForeignCurrencyTransactionGainLossBeforeTax",
                "unit": "usd",
                "value": -96893
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 219824
            },
            {
                "label": "Stock-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 1784102
            },
            {
                "label": "Gain from the sale of investment in BDI",
                "concept": "RealizedInvestmentGainsLosses",
                "unit": "usd",
                "value": 1605532
            },
            {
                "label": "Gain from the sale of investment in BDI",
                "concept": "RealizedInvestmentGainsLosses",
                "unit": "usd",
                "value": 1605532
            },
            {
                "label": "Purchases of held-to-maturity investment securities",
                "concept": "PaymentsToAcquireHeldToMaturitySecurities",
                "unit": "usd",
                "value": 11283940
            },
            {
                "label": "Net (decrease) increase in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -4888565
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 95366
            },
            {
                "label": "Proceeds from exercise of options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 1230050
            },
            {
                "label": "Unrealized gain from investment in Alphazyme",
                "concept": "UnrealizedGainLossOnInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Unrealized gain from investment in Alphazyme",
                "concept": "UnrealizedGainLossOnInvestments",
                "unit": "usd",
                "value": ""
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -11276945
            },
            {
                "label": "Amortization of held-to-maturity securities, net",
                "concept": "InvestmentIncomeAmortizationOfPremium",
                "unit": "usd",
                "value": 329612
            },
            {
                "label": "Interest receivable",
                "concept": "IncreaseDecreaseInAccruedInterestReceivableNet",
                "unit": "usd",
                "value": -17872
            },
            {
                "label": "Deferred research and development obligations",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": 28131
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 549562
            },
            {
                "label": "Cash received from income tax refund",
                "concept": "ProceedsFromIncomeTaxRefunds",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -13070251
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -13070251
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -13070251
            },
            {
                "label": "Proceeds from the sale of investment in BDI",
                "concept": "dyai:ProceedsFromSaleOfInvestmentInBDI",
                "unit": "usd",
                "value": 1605532
            },
            {
                "label": "Deferred license revenue",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": 500000
            },
            {
                "label": "Proceeds from maturities of investment securities",
                "concept": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities",
                "unit": "usd",
                "value": 14900000
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 1230050
            },
            {
                "label": "Net cash provided by investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 5221592
            }
        ],
        "ic": [
            {
                "label": "Unrealized gain from investment in Alphazyme",
                "concept": "UnrealizedGainLossOnInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Unrealized gain from investment in Alphazyme",
                "concept": "UnrealizedGainLossOnInvestments",
                "unit": "usd",
                "value": ""
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 8392370
            },
            {
                "label": "Loss before income taxes",
                "concept": "IncomeLossAttributableToParent",
                "unit": "usd",
                "value": -13070251
            },
            {
                "label": "Loss before income taxes",
                "concept": "IncomeLossAttributableToParent",
                "unit": "usd",
                "value": -13070251
            },
            {
                "label": "Gain from the sale of investments in BDI",
                "concept": "RealizedInvestmentGainsLosses",
                "unit": "usd",
                "value": 1605532
            },
            {
                "label": "Gain from the sale of investments in BDI",
                "concept": "RealizedInvestmentGainsLosses",
                "unit": "usd",
                "value": 1605532
            },
            {
                "label": "Total other income",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 1657236
            },
            {
                "label": "Research and development revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 2403831
            },
            {
                "label": "Provision for contract losses",
                "concept": "dyai:ProvisionForContractLosses",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -13070251
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -13070251
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -13070251
            },
            {
                "label": "Costs of research and development revenue",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 1944438
            },
            {
                "label": "Total costs and expenses",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 17131318
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 6697617
            },
            {
                "label": "Interest income",
                "concept": "InterestIncomeExpenseNonoperatingNet",
                "unit": "usd",
                "value": 51704
            },
            {
                "label": "Basic and diluted weighted-average common shares outstanding (in shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 27838047
            },
            {
                "label": "Foreign currency exchange loss",
                "concept": "ForeignCurrencyTransactionGainLossRealized",
                "unit": "usd",
                "value": -96893
            },
            {
                "label": "Basic and diluted net loss per common share (in dollars per share)",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.47
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -14727487
            }
        ]
    }
}